These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38108145)
21. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy. Yu J; Zhang Y; Li L; Xiang Y; Yao X; Zhao Y; Cai K; Li M; Li Z; Luo Z Acta Biomater; 2023 Oct; 169():434-450. PubMed ID: 37516418 [TBL] [Abstract][Full Text] [Related]
22. A Carrier-Free Nanomedicine Enables Apoptosis-Ferroptosis Synergistic Breast Cancer Therapy by Targeting Subcellular Organelles. Zhu J; Zhang K; Zhou Y; Wang R; Gong L; Wang C; Zhong K; Liu W; Feng F; Qu W ACS Appl Mater Interfaces; 2023 May; 15(18):22403-22414. PubMed ID: 37104698 [TBL] [Abstract][Full Text] [Related]
23. Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer. Qi X; Wan Z; Jiang B; Ouyang Y; Feng W; Zhu H; Tan Y; He R; Xie L; Li Y Front Immunol; 2022; 13():1038225. PubMed ID: 36505465 [TBL] [Abstract][Full Text] [Related]
24. Zwitterionic polymer coated sorafenib-loaded Fe Lin J; Zhang J; Wang K; Guo S; Yang W J Mater Chem B; 2022 Aug; 10(30):5784-5795. PubMed ID: 35861050 [TBL] [Abstract][Full Text] [Related]
25. Self-Assembled Oxaliplatin(IV) Prodrug-Porphyrin Conjugate for Combinational Photodynamic Therapy and Chemotherapy. Lim WQ; Yang G; Phua SZF; Chen H; Zhao Y ACS Appl Mater Interfaces; 2019 May; 11(18):16391-16401. PubMed ID: 31002492 [TBL] [Abstract][Full Text] [Related]
26. The potential of biomimetic nanoparticles for tumor-targeted drug delivery. Li B; Wang F; Gui L; He Q; Yao Y; Chen H Nanomedicine (Lond); 2018 Aug; 13(16):2099-2118. PubMed ID: 30226404 [TBL] [Abstract][Full Text] [Related]
27. Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles. Bai YT; Zhang XQ; Chen XJ; Zhou G Nanomedicine (Lond); 2022 Oct; 17(23):1761-1778. PubMed ID: 36647844 [TBL] [Abstract][Full Text] [Related]
29. Methotrexate loaded on magnetite iron nanoparticles coated with chitosan: Biosynthesis, characterization, and impact on human breast cancer MCF-7 cell line. Ali EMM; Elashkar AA; El-Kassas HY; Salim EI Int J Biol Macromol; 2018 Dec; 120(Pt A):1170-1180. PubMed ID: 30172815 [TBL] [Abstract][Full Text] [Related]
30. CCR2-overexpressing biomimetic carrier-free nanoplatform for enhanced cascade ferroptosis tumor therapy. Zhang X; Xu X; Liu H; Ni N; Liu S; Gong Y; Ma G; Song L; Meng Q; Fan Q; Sun X Acta Biomater; 2023 Aug; 166():604-614. PubMed ID: 37156432 [TBL] [Abstract][Full Text] [Related]
31. Biomimetic "Nanoplatelets" as a Targeted Drug Delivery Platform for Breast Cancer Theranostics. Li L; Fu J; Wang X; Chen Q; Zhang W; Cao Y; Ran H ACS Appl Mater Interfaces; 2021 Jan; 13(3):3605-3621. PubMed ID: 33449625 [TBL] [Abstract][Full Text] [Related]
33. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition. Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637 [TBL] [Abstract][Full Text] [Related]
34. Synergistic anticancer therapy via ferroptosis using modified bovine serum albumin nanoparticles loaded with sorafenib and simvastatin. Kuche K; Yadav V; Dharshini M; Ghadi R; Chaudhari D; Date T; Jain S Int J Biol Macromol; 2023 Dec; 253(Pt 8):127254. PubMed ID: 37813219 [TBL] [Abstract][Full Text] [Related]
35. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells. Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421 [TBL] [Abstract][Full Text] [Related]
36. Enhancing anti-cancer potential by delivering synergistic drug combinations via phenylboronic acid modified PLGA nanoparticles through ferroptosis-based therapy. Kuche K; Yadav V; Patel M; Chaudhari D; Date T; Jain S Biomater Adv; 2024 Jan; 156():213700. PubMed ID: 38042001 [TBL] [Abstract][Full Text] [Related]
37. Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer. Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Abadpour A; Moumivand E; Mojarrad JS; Rashidi MR; Coukos G; Omidi Y Colloids Surf B Biointerfaces; 2013 Jun; 106():117-25. PubMed ID: 23434700 [TBL] [Abstract][Full Text] [Related]
38. Progress in the Mechanism of the Effect of Fe Wang Y; Wu X; Bao X; Mou X Molecules; 2023 Jun; 28(11):. PubMed ID: 37299036 [TBL] [Abstract][Full Text] [Related]
39. Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer. Rezaei S; de Araújo Júnior RF; da Silva ILG; Schomann T; Eich C; Cruz LJ Biomater Adv; 2023 Aug; 151():213456. PubMed ID: 37196459 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic types and advantages of functionalized nanoparticles in inducing ferroptosis in cancer therapy. Wang Z; Zhao M; Huang X; Wang Y; Li W; Qiao J; Yang X Ann Med; 2024 Dec; 56(1):2396568. PubMed ID: 39276361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]